Navigation Links
Drugs With Marijuana Compounds Don't Boost Adverse Events
Date:6/28/2008

But Canadian study finds increase in non-serious side effects

FRIDAY June 27 (HealthDay News) -- Drugs that contain compounds called cannabinoids from the marijuana plant don't increase the risk of serious side effects but are associated with an increase in some non-serious side effects, Canadian scientists report.

The researchers at McGill University in Montreal and the University of British Columbia (UBC) examined adverse events reported in 31 clinical studies of cannabinoid medications conducted between 1966 and 2007.

The adverse events were grouped as serious or non-serious. Serious adverse events included those that led to hospitalization, disability or death. Non-serious adverse events included dizziness and drowsiness.

"Overall, we found an 86 percent increase in the rate of non-serious adverse events among the patients treated with cannabinoids compared to the patients in the control groups," Dr. Mark Ware, a neurosciences researcher at the Research Institute of the McGill University Health Centre, said in a prepared statement.

Most of the non-serious side effects were mild to moderate in severity.

The study was published in the June 16 issue of the Canadian Medical Association Journal.

Cannabinoids have been shown to help treat chronic pain from diseases such as cancer, multiple sclerosis, arthritis and fibromyalgia. The drugs also stimulate appetite and relieve nausea, according to background information in the study.

Doctors must balance the benefits of these drugs against possible side effects, the researchers said.

"We have summarized the adverse events from these studies to help educate physicians and patients about the possible risks of medical cannabinoids. We cannot extend these results to smoked cannabis or recreational use. That will require further research," Dr. Jean-Paul Collet, senior researcher at the Child & Family Research Institute and director of the Centre for Applied Health Research and Evaluation at British Columbia Children's Hospital, said in a prepared statement.

More information

The National Pain Foundation has more about cannabinoids.



-- Robert Preidt



SOURCE: McGill University, news release, June 16, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. ADHD Gene Doesnt Predict Response to Drugs
2. Failure to Take Seizure Drugs Boosts Death Risk
3. Computers as safe as medical experts in prescribing blood thinning drugs
4. Drink and drugs fuel Scottish suicide and homicide rates
5. New Class of Drugs May Fight Alzheimers
6. Targeted Anticancer Drugs - In Vitro Assessment and Non-Invasive Imaging of Patient and Tumor Status Will Determine Clinical and Commercial Success
7. FDA Starts Safety Review of Autoimmune Disorder Drugs
8. Synthetic molecules hold promise for new family of anti-cancer drugs
9. Isis Partners Present Clinical Data on Antisense Drugs at the American Society of Clinical Oncology
10. Anemia Drugs May Speed Tumor Growth in Some Cancer Patients
11. China Nepstar Chain Drugstore Filed Its Annual Report on Form 20-F
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... Shelton, CT (PRWEB) , ... October 13, 2017 , ... ... and long-term care services, staged a mock evacuation of the facility as part of ... Department, Shelton Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at ... of the most popular and least understood books in the Holy Scriptures, Revelation. The ... that have baffled scholars for centuries. Many have tossed it off as mere rubbish, ...
(Date:10/12/2017)... WILMINGTON, Del. (PRWEB) , ... October 12, 2017 ... ... technology and advisory services for healthcare compliance program management, will showcase a range ... and National Association for Assisted Living (NCAL) Convention and Expo to be held ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s ... the 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)...  BioPharmX Corporation (NYSE MKT: BPMX) researchers were part ... way to use nonlinear optical imaging to confirm the ... A presentation ... how researchers from BioPharmX and the Wellman Center for ... suite of imaging techniques in what is called "Pharmacokinetic ...
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/4/2017)... , Oct. 4, 2017  South Korean-based healthcare ... CPR training aide "cprCUBE" on Kickstarter. The device will ... during cardiac arrests with better efficiency compared to the ... offers real-time feedback on efficacy of the compression for ... campaign has a goal to raise $5,000. ...
Breaking Medicine Technology: